BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI)

CUSIP: 09075P105

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
26,011,000
Total 13F shares
4,695,186
Share change
+4,695,186
Total reported value
$47,920,000
Price per share
$10.24
Number of holders
22
Value change
+$47,920,000
Number of buys
22

Quarterly Holders Quick Answers

What is CUSIP 09075P105?
CUSIP 09075P105 identifies BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) as of Q1 2018

As of 31 Mar 2018, BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,695,186 shares. The largest 10 holders included FMR LLC, Artemis Investment Management LLP, BARCLAYS PLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, VANGUARD GROUP INC, ASCEND CAPITAL, LLC, Monashee Investment Management LLC, Marshall Wace North America L.P., Point72 Asset Management, L.P., and Dean Capital Investments Management, LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2018 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q1 2018 holders
22
Holder diff
21
Investor Q3 2025 Shares Q1 2018 Shares Share Diff Share Chg % Q3 2025 Value $ Q1 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .